[28], the effect of the addition of Granulocyte-Colony Stimulating Factor (G-CSF) to imatinib has been simulated, assuming different cycling-to-non-cycling ratios of wild-type CML stem cells. Here, CSF3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.